• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Pulmonary phagocyte-derived NPY controls the pathology of severe influenza virus infection

tetano

Editor, Senior Moderator
Nat Microbiol. 2018 Nov 19. doi: 10.1038/s41564-018-0289-1. [Epub ahead of print]
[h=1]Pulmonary phagocyte-derived NPY controls the pathology of severe influenza virus infection.[/h] Fujiwara S[SUP]1[/SUP], Hoshizaki M[SUP]1[/SUP], Ichida Y[SUP]1[/SUP], Lex D[SUP]2[/SUP], Kuroda E[SUP]3,[/SUP][SUP]4[/SUP], Ishii KJ[SUP]3,[/SUP][SUP]4[/SUP], Magi S[SUP]5[/SUP], Okada M[SUP]5,[/SUP][SUP]6[/SUP], Takao H[SUP]1[/SUP], Gandou M[SUP]1[/SUP], Imai H[SUP]1[/SUP], Hara R[SUP]1[/SUP], Herzog H[SUP]7[/SUP], Yoshimura A[SUP]8[/SUP], Okamura H[SUP]9[/SUP], Penninger JM[SUP]10,[/SUP][SUP]11[/SUP], Slutsky AS[SUP]12,[/SUP][SUP]13[/SUP], Uhlig S[SUP]2[/SUP], Kuba K[SUP]14[/SUP], Imai Y[SUP]15,[/SUP][SUP]16[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Crosstalk between the autonomic nervous system and the immune system by means of the sympathetic and parasympathetic pathways is a critical process in host defence. Activation of the sympathetic nervous system results in the release of catecholamines as well as neuropeptide Y (NPY). Here, we investigated whether phagocytes are capable of the de novo production of NPY, as has been described for catecholamines. We show that the synthesis of NPY and its Y1 receptor (Y1R) is increased in phagocytes in lungs following severe influenza virus infection. The genetic deletion of Npy or Y1r specifically in phagocytes greatly improves the pathology of severe influenza virus infection, which is characterized by excessive virus replication and pulmonary inflammation. Mechanistically, it is the induction of suppressor of cytokine signalling 3 (SOCS3) via NPY-Y1R activation that is responsible for impaired antiviral response and promoting pro-inflammatory cytokine production, thereby enhancing the pathology of influenza virus infection. Thus, direct regulation of the NPY-Y1R-SOCS3 pathway on phagocytes may act as a fine-tuner of an innate immune response to virus infection, which could be a therapeutic target for lethal influenza virus infection.


PMID: 30455472 DOI: 10.1038/s41564-018-0289-1
 
Back
Top Bottom